Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Novel Drug Combinations for Advanced Breast Cancer
Link ID 2545
Title Novel Drug Combinations for Advanced Breast Cancer
Url http://www.medscape.com/viewarticle/568165?src=rss
Description In this Expert Interview from SABCS 2007, Dr. William J. Gradishar details the latest novel drug combinations that may benefit patients with advanced breast cancer.
Medscape Hematology-Oncology
Category Articles > Hematology-Oncology
Keywords
Date Jan 19, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Pathological Complete Response of Breast Tumors to Specific Chemotherapies Can Be Predicted
  A phase 3 clinical trial has confirmed the predictive validity of gene-expression signatures and drug responses established in vitro. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. Toremifene Reduces Fractures and Hot Flashes From ADT in Prostate Cancer
  Toremifene reduces hot flashes and vertebral fractures in men with prostate cancer on androgen-deprivation therapy for prostate cancer. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. ESAs Should Continue to be Used for Anemia in Cancer Patients, Says FDA Advisory Committee
  Erythropoiesis-stimulating agents should continue to have an oncology indication, even though questions about their safety remain. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Survival Benefit Seen With Radiation Therapy in Early Pancreatic Cancer
  Adjuvant external-beam radiation therapy (EBRT) improves survival in patients with operable, lymph node-negative pancreatic cancer, according to a report in the January 1st issue of Cancer. Reuters Health Information
Category:   Articles > Hematology-Oncology


5. Alpha1-Antitrypsin Deficiency Significantly Increases Risk for Lung Cancer
  Carriers of the alpha1-antitrypsin deficiency might have a risk of developing lung cancer that is up to 70% higher than that for noncarriers of the genetic defect. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS